Comparing the Benefit of Novel Therapies Across Clinical Trials: Insights From the VICTORIA Trial

Circulation - United States
doi 10.1161/circulationaha.120.047086
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

From Clinical Insights to New Therapies

American Journal of Physiology - Regulatory Integrative and Comparative Physiology
Physiology
2006English

Clinical Trials of Neuroprotective Therapies

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2007English

Targeted Therapies in Cholangiocarcinoma: Emerging Evidence From Clinical Trials

Medicina
Medicine
2019English

Clinical Trial Highlights – Infusion Therapies

Journal of Parkinson's Disease
Molecular NeuroscienceNeurologyCellular
2020English

Aldosterone, Hypertension and Heart Failure: Insights From Clinical Trials

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2010English

A Bayesian Analysis of a Randomized Clinical Trial Comparing Antimetabolite Therapies for Non-Infectious Uveitis

Ophthalmic Epidemiology
EpidemiologyOphthalmology
2016English

Defining Risks of Taxane Neuropathy: Insights From Randomized Clinical Trials

Clinical Cancer Research
Cancer ResearchOncology
2013English

New Section: Novel Insights From Clinical Practice

Molecular Syndromology
Genetics
2015English

Clinical Benefit in Phase-I Trials of Novel Molecularly Targeted Agents: Does Dose Matter?

British Journal of Cancer
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy